Skip to main content
. 2018 Oct 16;11:169–178. doi: 10.2147/PGPM.S170515

Table 4.

Effect of CYP2C9 and VKORC1 on mean dose (mg/week), according to genotype and sensitivity group

Gene Genotype Mean dose (mg/week) P-value

VKORCI GG 39.33 (mg/week) 0.0001
AA 22.95 (mg/week)
CYP2C9 *l/*l 33.14 (mg/week) 0.001
*2/*2 *2/*3 20 (mg/week)

Sensitivity groups Mean dose (mg/week) P-value Adverse drug reactions P-value

Normal (n=104) 35.53 (mg/week) 0.001 35.6% (n=37) 0.002
Moderate (n=44) 25.21 (mg/week) 65.9% (n=29)
High (n=4) 15.6 (mg/week) 75% (n=3)